Stay updated on Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.

Latest updates to the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label was updated from 'Intervention / Treatment' to 'Intervention/Treatment'. Recruitment status was updated to 'No longer looking for participants' and the site revision footer changed from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check20 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor backend or UI update. No changes were made to the displayed study details or related content.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision v3.5.4 was added to the study's record, replacing the previous v3.5.3. This signals a new version of the page, likely reflecting minor updates to the study record or its metadata rather than a substantive change to study content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision tag updated to v3.5.3, replacing the previous v3.5.2. This indicates an update to the page version rather than changes to the study data or visible content.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision updated to v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.